LAUREN SCARBOROUGH: Open Payments
NPI 1679097794 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 56 payments from 14 companies in 2025. Trend: 2023 $73 · 2024 $418 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $210 |
| Novartis Pharmaceuticals Corporation | 9 | $196 |
| TG Therapeutics, Inc. | 5 | $115 |
| Neurocrine BioSciences, Inc. | 5 | $114 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| Genentech USA, Inc. | 2 | $56 |
| UCB, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $36 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Eisai Inc. | 1 | $31 |
Products named: KESIMPTA, UBRELVY, BRIUMVI, INGREZZA, AUSTEDO XR, Ocrevus Zunovo, BOTOX, KISUNLA.
Industry payments across SC — which companies pay providers there.
